Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Devin Saunders"'
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionBreast cancer continues to be the leading form of cancer among women in the United States. Additionally, disparities across the breast cancer continuum continue to increase for women of historically marginalized populations. The mechanism
Externí odkaz:
https://doaj.org/article/ea69547ea08245ad962808686d98f72a
Autor:
Allison B. Powell, Yanqin Ren, Maria Korom, Devin Saunders, Patrick J. Hanley, Harris Goldstein, Douglas F. Nixon, Catherine M. Bollard, Rebecca M. Lynch, R. Brad Jones, Conrad Russell Y. Cruz
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 19, Iss , Pp 78-88 (2020)
While antiretroviral therapy (ART) can completely suppress viremia, it is not a cure for HIV. HIV persists as a latent reservoir of infected cells, able to evade host immunity and re-seed infection following cessation of ART. Two promising immunother
Externí odkaz:
https://doaj.org/article/f8e6ea291a00474abdba97036edada0b
Autor:
Shabnum Patel, Ryo Hanajiri, Melanie Grant, Devin Saunders, Stacey Van Pelt, Michael Keller, Patrick J. Hanley, Gary Simon, Douglas F. Nixon, David Hardy, R. Brad Jones, Catherine M. Bollard
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 16, Iss , Pp 11-20 (2020)
Although anti-retroviral therapy (ART) is successful in suppressing HIV-1 replication, HIV latently infected reservoirs are not eliminated, representing a major hurdle in efforts to eradicate the virus. Current strategies to eradicate HIV involve two
Externí odkaz:
https://doaj.org/article/e8d6b4890951402e887839e12bd1681f
Autor:
Allison B. Powell, Sridevi Yadavilli, Devin Saunders, Stacey Van Pelt, Elizabeth Chorvinsky, Rachel A. Burga, Shuroug Albihani, Patrick J. Hanley, Zhenhua Xu, Yanxin Pei, Eric S. Yvon, Eugene I. Hwang, Catherine M. Bollard, Javad Nazarian, Conrad Russell Y. Cruz
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-10 (2019)
Abstract Background Medulloblastoma (MB), the most common pediatric brain cancer, presents with a poor prognosis in a subset of patients with high risk disease, or at recurrence, where current therapies are ineffective. Cord blood (CB) natural killer
Externí odkaz:
https://doaj.org/article/c9184b94467c470fae4a1a2e1c6345e2
Autor:
David Hardy, Patrick J. Hanley, R. Brad Jones, Catherine M. Bollard, Shabnum Patel, Melanie Grant, Douglas F. Nixon, Stacey Van Pelt, Michael D. Keller, Ryo Hanajiri, Gary L. Simon, Devin Saunders
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 16, Iss, Pp 11-20 (2020)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Although anti-retroviral therapy (ART) is successful in suppressing HIV-1 replication, HIV latently infected reservoirs are not eliminated, representing a major hurdle in efforts to eradicate the virus. Current strategies to eradicate HIV involve two
Publikováno v:
Cancer Research. 83:B013-B013
Introduction: Age is a strong predictor for breast cancer (BCa) risk. The median age at diagnosis varies by race/ethnicity. In the United States (U.S.), non-White women are more likely to be diagnosed at a younger age than non-Hispanic White (NHW) wo
Autor:
Stacey Van Pelt, Javad Nazarian, Zhenhua Xu, Elizabeth Chorvinsky, Devin Saunders, Yanxin Pei, Allison B. Powell, Sridevi Yadavilli, Eugene Hwang, Eric Yvon, Catherine M. Bollard, Conrad Russell Y. Cruz, Shuroug Albihani, Rachel A. Burga, Patrick J. Hanley
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-10 (2019)
Journal of Translational Medicine
Journal of Translational Medicine
Background Medulloblastoma (MB), the most common pediatric brain cancer, presents with a poor prognosis in a subset of patients with high risk disease, or at recurrence, where current therapies are ineffective. Cord blood (CB) natural killer (NK) cel
Publikováno v:
Cell and Gene Therapy Insights. 4:1059-1072
Autor:
Jeffrey S. Dome, Payal Banerjee, Yunfei Wang, Maria Fernanda Fortiz, Holly J. Meany, C. Russell Cruz, Amy B. Hont, Fahmida Hoq, Robert Ulrey, Shuroug Albihani, Barbara O’Brien, Devin Saunders, Patrick J. Hanley, Haili Lang, Catherine M. Bollard, Maja Stanojevic, Ryo Hanajiri, Sam Darko, Karuna Panchapakesan, Anushree Datar
PURPOSE Tumor-associated antigen cytotoxic T cells (TAA-Ts) represent a new, potentially effective and nontoxic therapeutic approach for patients with relapsed or refractory solid tumors. In this first-in-human trial, we investigated the safety of ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4450fc042134532c3b0a9f8f98a46c2a
https://europepmc.org/articles/PMC6804838/
https://europepmc.org/articles/PMC6804838/
Autor:
Kim Y. Green, Abha Chopra, Simon Mallal, Patrick J Hanley, Devin Saunders, Ryo Hanajiri, Stanislav V. Sosnovtsev, Jeffrey I. Cohen, Gelina M. Sani, Michael D Keller, Catherine M. Bollard
Publikováno v:
J Infect Dis
Background Chronic norovirus infection in immunocompromised patients can be severe, and presently there is no effective treatment. Adoptive transfer of virus-specific T cells has proven to be safe and effective for the treatment of many viral infecti